Printer Friendly

MYCOGEN'S M-PERIL(TM) BIOINSECTICIDE APPROVED BY EPA FOR COMMERCIAL USE AGAINST CORN BORER

 SAN DIEGO, Feb. 4 /PRNewswire/ -- Mycogen Corp. (NASDAQ: MYCO) announced today that its genetically engineered M-Peril(TM) bioinsecticide, which targets the European corn borer, has been approved by the U.S. Environmental Protection Agency (EPA) for commercial sale.
 Mycogen Chairman, President and Chief Executive Officer Jerry Caulder said the registration is significant, both in terms of the new product's sales potential and as a continuing regulatory validation of the company's CellCap(R) encapsulation delivery system.
 "We estimate the sales potential for M-Peril(TM) to be $20-50 million a year," Caulder said. "In addition, the fact that we obtained this registration in less than a year demonstrates that the EPA understands, and is comfortable with, our biopesticide technology."
 Mycogen's CellCap(R) encapsulation system employs recombinant DNA technology to transfer the genetic blueprint for production of natural protein toxins from Bt into another bacterium, Pseudomonas fluorescens (Pf). The genetically engineered Pf cells produce the toxin and are mass produced through fermentation. Finally, the microbes are killed through a process that reinforces their cell walls, forming tiny biocapsules that protect the fragile toxin crystals, prolonging their activity in the field.
 M-Peril(TM) is the third EPA-approved Mycogen product using this delivery system. In 1991, the company's MVP(R) and M-Trak(TM) bioinsecticides became the first two genetically engineered biopesticides to receive federal regulatory approval for commercial sale, and both subsequently were registered in all 50 states.
 Each of these products is highly specific to one or more target pests and is harmless to animals and beneficial insects. All of them break down naturally, leaving no toxic residue in food, water or soil.
 Mycogen will introduce M-Peril(TM) on a limited basis for the upcoming growing season.
 "We'll get our feet wet this year and ramp up production and marketing for a full-scale introduction in 1994," Caulder said. Mycogen is a diversified agricultural biotechnology company that develops and markets biopesticides and improved crop varieties to control pests and increase food production.
 -0- 2/4/93
 /CONTACT: Mike Sund of Mycogen Corp., 619-453-8030/
 (MYCO)


CO: Mycogen Corp. ST: California IN: CHM SU: PDT

JB-LS -- SD003 -- 2763 02/04/93 08:33 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 4, 1993
Words:357
Previous Article:RALPH LAUREN FRAGRANCES PRESENTS VALENTINE'S DAY GIFT SETS FOR HER OR HIM
Next Article:QUIDEL REPORTS INCREASED THIRD QUARTER SALES
Topics:


Related Articles
ECOGEN RECEIVES EPA EXEMPTION FOR FIELD EVALUATION OF RECOMBINANT BT STRAINS
CROP GENETICS REPORTS IMPROVED CONTROL WITH CORN BIOINSECTICIDE
MYCOGEN'S MVP(R) BIOINSECTICIDE REGISTERED FOR COMMERCIAL SALE IN MEXICO
EPA APPROVES CROP GENETICS' BIOINSECTICIDE; SPOD-X(TM) IS FIRST NEW INSECT VIRUS APPROVED IN 10 YEARS
MYCOGEN RESTRUCTURES, PUSHES FOR PROFITABILITY
MYCOGEN RESTRUCTURES, PUSHES FOR PROFITABILITY
MYCOGEN TO TEST BIOINSECTICIDES, INSECT-RESISTANT CORN PLANTS UNDER EXPERIMENTAL USE PERMITS ISSUED BY EPA
ECOGEN RECEIVES THREE NEW PHEROMONE PRODUCT APPROVALS; EPA REGISTRATIONS FOR NOMATE LINE TOTAL SEVEN
FIRST EPA BIOFUNGICIDE REGISTRATION FOR CONTROL OF POSTHARVEST FRUIT ROTS
ECOGEN RECEIVES EPA APPROVAL OF CRYMAX BIOINSECTICIDE

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters